Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p53 Family isoforms.

Jean-Christophe Bourdon1

  • 1University of Dundee, Ninewells Hospital, Department of Surgery, CR-UK Cell Transformation Research Group, UK. j.bourdon@dundee.ac.uk

Current Pharmaceutical Biotechnology
|February 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EPIclip: A Novel Approach for the Production of Decorated Virus-Like Particles Mediated by High-Affinity Protein Binding Partners.

Vaccines·2026
Same author

Correction: <i>TP53</i> drives invasion through expression of its Δ133p53β variant.

eLife·2025
Same author

Mutant mice lacking alternatively spliced p53 isoforms unveil <i>Ackr4</i> as a male-specific prognostic factor in Myc-driven B-cell lymphomas.

eLife·2024
Same author

Germline variant affecting p53β isoforms predisposes to familial cancer.

Nature communications·2024
Same author

It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort.

Cancer cell international·2023
Same author

Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.

Scottish medical journal·2022
Same journal

Therapeutic Applications and Advancements of Exosome-Based Treatments - A Comprehensive Review.

Current pharmaceutical biotechnology·2026
Same journal

Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant Bacteria.

Current pharmaceutical biotechnology·2026
Same journal

Unveiling Aptamers for Targeted Tumour Therapies and Detection: Systematic Evolution of Ligands by Exponential Enrichment (SELEX) Technology in Oncology.

Current pharmaceutical biotechnology·2026
Same journal

Nanosuspensions-Based Dry Powder Inhalers for Pulmonary Delivery of Hydrophobic Natural Products: Formulation Strategies, Efficacy, and Challenges.

Current pharmaceutical biotechnology·2026
Same journal

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Rat Wound Healing by Inhibiting Pyroptosis through the NLRP3/Caspase-1/GSDMD Pathway.

Current pharmaceutical biotechnology·2026
Same journal

Cyperotundone Regulates Polo-like Kinase 1-mediated Glycolysis to Inhibit the Proliferation of Breast Cancer Cells.

Current pharmaceutical biotechnology·2026
See all related articles

The p53 gene family, including p63 and p73, is crucial for cell regulation. Inactivation of the p53 pathway is common in cancer, impacting prognosis and diagnosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The p53 gene family, comprising p53, p63, and p73, are critical transcription factors involved in development, differentiation, and cellular stress responses.
  • p53 gene mutations occur in approximately 50% of human cancers, and even in non-mutated cases, the tumor suppressor pathway can be inactivated through protein interactions.
  • Inactivation of the p53 pathway is a common hallmark of cancer, yet its direct correlation with clinical prognosis and diagnosis remains challenging.

Purpose of the Study:

  • To explore the complex interplay between p53, p63, and p73 isoforms in the context of cancer development.
  • To highlight recent advancements that may deepen the understanding of p53's tumor suppressor functions.
  • To investigate the significance of the dual gene structure and alternative splicing in generating diverse p53 family protein isoforms.

Related Experiment Videos

Main Methods:

  • Review of recent scientific literature focusing on the p53 gene family and cancer.
  • Analysis of the conserved dual gene structure of p63, p73, and p53 across species.
  • Examination of mechanisms generating protein isoforms, including alternative splicing and promoter usage.

Main Results:

  • p53 pathway inactivation is a unifying feature across various cancers.
  • The generation of multiple protein isoforms from p63, p73, and p53 genes through alternative splicing and translation initiation.
  • The conserved dual gene structure suggests fundamental biological roles for these proteins and their isoforms.

Conclusions:

  • Understanding the intricate interplay between p53, p63, and p73 isoforms is essential for deciphering tumor formation mechanisms.
  • Further research into p53 family dynamics may provide novel insights into cancer diagnosis and therapeutic strategies.
  • The complexity arising from alternative splicing and isoform generation is a key area for future investigation in cancer biology.